After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
TMO belongs to the Healthcare sector of the NYSE while operating in the Diagnostics & Research industry. The current market capitalization of Thermo Fisher Scientific Inc is $213.31B. A total of 1.83 million shares were traded on the day, compared to an average of 2.10M shares.
In the most recent transaction, Pettiti Gianluca sold 400 shares of TMO for 574.15 per share on Oct 24 ’25. After the transaction, the Executive Vice President now owns 21,152 company shares. In a previous transaction on Oct 24 ’25, CASPER MARC N sold 17,104 shares at 573.54 per share. TMO shares that Chairman & CEO owns now total 113,762.
Among the insiders who sold shares, CASPER MARC N disposed of 7,250 shares on Oct 27 ’25 at a per-share price of $566.10. This resulted in the Chairman & CEO holding 113,762 shares of TMO after the transaction. In another insider transaction, CASPER MARC N bought 7,250 shares at $566.10 per share on Oct 27 ’25.
Dividend
Paying dividends generates immediate cash flow for investors and indicates a positive outlook for the company. Thermo Fisher Scientific Inc pays an annual dividend of $1.68, resulting in a dividend yield of 0.30%, and it has a price to earnings (P/E) ratio of 32.64.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, TMO has a high of $610.97 and a low of $385.46.
As of this writing, TMO has an earnings estimate of $6.45 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $6.52 per share and a lower estimate of $6.39. The company reported an EPS of $6.1 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. TMO’s latest balance sheet shows that the firm has $4.48B in Cash & Short Term Investments as of fiscal 2021. There were $34.87B in debt and $13.44B in liabilities at the time. Its Book Value Per Share was $135.79, while its Total Shareholder’s Equity was $40.98B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMO is Buy with a score of 4.48.
